Stop-flow thoracic perfusion for unresectable pulmonary carcinoma with or without inhalation IL-2 immunotherapy. A prospective randomized study

Hepato-Gastroenterology

Volumn 46, Issue 26, 1999, Pages 792-798

  Lygidakis, N J ^a,b   Safioleas, M ^a   Sgourakis, G ^a   Aphinives, P ^a  

^a ATHENS MEDICAL CENTER   (Greece)

^b NONE   (Greece)

Author keywords

Inhalation IL 2 therapy; Lung cancer; Regional chemotherapy; Regional immunotherapy; Stop flow perfusion

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 2; MITOMYCIN C; RECOMBINANT INTERLEUKIN 2;

ADULT; AGED; ARTICLE; BALLOON CATHETER; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INOPERABLE CANCER; LUNG CARCINOMA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERFUSION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THORAX;

ADMINISTRATION, INHALATION; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BALLOON DILATATION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOTHERAPY; INFUSIONS, INTRA-ARTERIAL; INTERLEUKIN-2; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0032904447     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. 1 Aigner KR: Aortic stopflow infusion (ASI) and hypoxic abdominal perfusion (HAP) for disseminated bulky peritoneal carcinomatosis - rationale and technique Reg Cancer Treat 1993; 6(Suppl 1):3.
2. 2 Aigner KR, Gailhofer S: Celiac axis infusion (MMC, CDDP, 5-FU) and aortic stop-flow infusion vs. abdominal hypoxic perfusion (MMC) in UICC stage III/IV pancreatic cancer - 48 patients. Reg Cancer Treat 1993; 6(Suppl 1):3.
3. 3 Aigner KR: Regional chemotherapy. Editorial review article. Reg Cancer Treat 1994; 2:55-66.
4. 4 Aigner KR, Kaevel K: Pelvic slop flow infusion (PSI) and hypoxic pelvic perfusion (HPP) with mitomycin and melphalan for recurrent rectal cancer. Reg Cancer Treat 1994; 1:6-11.
5. 5 Aigner KR: Pelvic stop flow infusion and hypoxic pelvic perfusion - technique and pharmacokinetics. Reg Cancer Treat. (In press)
6. 6 Muchmore JK, Krementz ET, Carter RD: Management of advanced intraabdominal malignancy using high-dose intra-arterial chemotherapy with concomitant hemofiltration. Reg Cancer Treat 1990; 3:211-215.
7. 7 Turk PS, Belliveau JF, Darnowski JW: Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg 1993; 128:533-539.